Macrophage-produced IL-10 limits the chemotherapy efficacy in breast cancer

Affiliations

Comment

Xinguo Jiang. J Zhejiang Univ Sci B. 2015 Jan.

. 2015 Jan;16(1):44-5.

doi: 10.1631/jzus.B1400352.

¹ Department of Medicine, VA Palo Alto Health Care System/Stanford University School of Medicine, Stanford, CA 94305, USA.

No abstract available

Comment on

Macrophage IL-10 blocks CD8+ T cell-dependent responses to chemotherapy by suppressing IL-12 expression in intratumoral dendritic cells.
Ruffell B, Chang-Strachan D, Chan V, Rosenbusch A, Ho CM, Pryer N, Daniel D, Hwang ES, Rugo HS, Coussens LM. Ruffell B, et al. Cancer Cell. 2014 Nov 10;26(5):623-37. doi: 10.1016/j.ccell.2014.09.006. Epub 2014 Oct 16. Cancer Cell. 2014. PMID: 25446896 Free PMC article.

1. de Palma M, Lewis CE. Macrophage regulation of tumor responses to anticancer therapies. Cancer Cell. 2013;23(3):277–286. doi: 10.1016/j.ccr.2013.02.013. - DOI - PubMed
1. DeNardo DG, Brennan DJ, Rexhepaj E, et al. Leukocyte complexity predicts breast cancer survival and functionally regulates response to chemotherapy. Cancer Discov. 2011;1(1):54–67. doi: 10.1158/2159-8274.CD-10-0028. - DOI - PMC - PubMed
1. Germano G, Frapolli R, Belgiovine C, et al. Role of macrophage targeting in the antitumor activity of trabectedin. Cancer Cell. 2013;23(2):249–262. doi: 10.1016/j.ccr.2013.01.008. - DOI - PubMed
1. Jiang X. Harnessing the immune system for the treatment of breast cancer. J Zhejiang Univ-Sci B (Biomed & Biotechnol) 2014;15(1):1–15. doi: 10.1631/jzus.B1300264. - DOI - PMC - PubMed
1. Noy R, Pollard JW. Tumor-associated macrophages: from mechanisms to therapy. Immunity. 2014;41(1):49–61. doi: 10.1016/j.immuni.2014.06.010. - DOI - PMC - PubMed